Literature DB >> 26274057

Ex Vivo Culture of Pharyngeal Arches to Study Heart and Muscle Progenitors and Their Niche.

Peter Andersen1, Chulan Kwon2.   

Abstract

The pharyngeal mesoderm of developing embryos contributes to broad regions of head and heart musculature. We have developed a novel method to study head and heart progenitor cell development with pharyngeal arches (also known as branchial arches) ex vivo. Using this method, we have recently described that the second pharyngeal arch contains self-renewing heart progenitors and serves as a microenvironment for expansion of the progenitors during mouse heart development. The progenitor cells remain undifferentiated and expansive inside the arch, but quickly become functional cardiomyocytes as they migrate out of the arch. We also reported that first pharyngeal arch contains muscle progenitors giving rise to myotubes after leaving the arch. Here, we demonstrate the procedure for the dissection and ex vivo culture of first and second pharyngeal arches from developing mouse embryos. The method enables one to study head and heart progenitor/muscle development, including cardiomyocyte and myotube formation in detail ex vivo.

Entities:  

Mesh:

Year:  2015        PMID: 26274057      PMCID: PMC4545119          DOI: 10.3791/52876

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  10 in total

Review 1.  The second heart field.

Authors:  Robert G Kelly
Journal:  Curr Top Dev Biol       Date:  2012       Impact factor: 4.897

Review 2.  Pharyngeal mesoderm development during embryogenesis: implications for both heart and head myogenesis.

Authors:  Eldad Tzahor; Sylvia M Evans
Journal:  Cardiovasc Res       Date:  2011-04-15       Impact factor: 10.787

Review 3.  The pharyngeal pouches and clefts: Development, evolution, structure and derivatives.

Authors:  Armelle Grevellec; Abigail S Tucker
Journal:  Semin Cell Dev Biol       Date:  2010-02-08       Impact factor: 7.727

Review 4.  Regenerative medicine for the heart: perspectives on stem-cell therapy.

Authors:  Gun-Sik Cho; Laviel Fernandez; Chulan Kwon
Journal:  Antioxid Redox Signal       Date:  2014-09-22       Impact factor: 8.401

Review 5.  The developmental genetics of congenital heart disease.

Authors:  Benoit G Bruneau
Journal:  Nature       Date:  2008-02-21       Impact factor: 49.962

6.  Fibronectin mediates mesendodermal cell fate decisions.

Authors:  Paul Cheng; Peter Andersen; David Hassel; Bogac L Kaynak; Pattraranee Limphong; Lonny Juergensen; Chulan Kwon; Deepak Srivastava
Journal:  Development       Date:  2013-06       Impact factor: 6.868

7.  Wnt/beta-catenin signaling acts at multiple developmental stages to promote mammalian cardiogenesis.

Authors:  Chulan Kwon; Kimberly R Cordes; Deepak Srivastava
Journal:  Cell Cycle       Date:  2008-12-13       Impact factor: 4.534

8.  Direct contact with endoderm-like cells efficiently induces cardiac progenitors from mouse and human pluripotent stem cells.

Authors:  Hideki Uosaki; Peter Andersen; Lincoln T Shenje; Laviel Fernandez; Sofie Lindgren Christiansen; Chulan Kwon
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

9.  Precardiac deletion of Numb and Numblike reveals renewal of cardiac progenitors.

Authors:  Lincoln T Shenje; Peter Andersen; Hideki Uosaki; Laviel Fernandez; Peter P Rainer; Gun-Sik Cho; Dong-Ik Lee; Weimin Zhong; Richard P Harvey; David A Kass; Chulan Kwon
Journal:  Elife       Date:  2014-04-24       Impact factor: 8.140

10.  A regulatory pathway involving Notch1/beta-catenin/Isl1 determines cardiac progenitor cell fate.

Authors:  Chulan Kwon; Li Qian; Paul Cheng; Vishal Nigam; Joshua Arnold; Deepak Srivastava
Journal:  Nat Cell Biol       Date:  2009-07-20       Impact factor: 28.824

  10 in total
  1 in total

1.  β1-integrin is a cell-autonomous factor mediating the Numb pathway for cardiac progenitor maintenance.

Authors:  Brian C Gibbs; Lincoln Shenje; Peter Andersen; Matthew Miyamoto; Chulan Kwon
Journal:  Biochem Biophys Res Commun       Date:  2018-04-13       Impact factor: 3.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.